4//SEC Filing
Wambeke David J. 4
Accession 0001437749-25-019296
CIK 0001401040other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:19 PM ET
Size
5.9 KB
Accession
0001437749-25-019296
Insider Transaction Report
Form 4
Wambeke David J.
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2025-06-01+250,000→ 250,000 totalExercise: $4.11Exp: 2035-05-31→ Common Shares (250,000 underlying)
Holdings
- 527,114
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001971798
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:19 PM ET
- Size
- 5.9 KB